Cosmo Pharmaceuticals Highlights Study Published in “The Lancet” Demonstrating the Efficacy of GI Genius™ in Colonoscopy Procedures

· Cosmo Pharmaceuticals NV

Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V. (“Cosmo”), the developer and manufacturer of the GI Genius™ intelligent endoscopy system, is pleased to announce the publication of a study in “The Lancet”. This study, titled “Polyp detection with colonoscopy assisted by the GI Genius™ artificial intelligence endoscopy module compared with standard colonoscopy in routine colonoscopy practice (COLO-DETECT): a multicentre, open-label, parallel-arm, randomised controlled trial”, represents a significant advancement in colorectal cancer screening and detection.

Download press release (PDF)

← All news